BackgroundCheck.run
Search For

Nandini B Patel, 66Saint Cloud, FL

Known as:
Nandini E Patel Nandini I Patel Nera Lee Patel Nandine Patel Nb Patel Patel B Nandini Patel Nera
Related to:
Sebastian Herzig 38

Nandini Patel Phones & Addresses

Saint Cloud, FL   

Pasadena, CA   

Camarillo, CA   

21 Medbury Rd, North Attleboro, MA 02760    508-6953953   

209 Main St, Attleboro, MA 02703   

N Attleboro, MA   

Get Report
Control this profile

Mentions for Nandini B Patel

Career records & work history

Medicine Doctors

Nandini A. Patel

Specialties:
Psychiatry
Work:
Independence Therapy Center
700 Independence Cir STE 3D, Virginia Beach, VA 23455
757-4738533 (phone) 757-4560616 (fax)
Education:
Medical School
Baroda Medical College, Gujarat, India
Graduated: 1979
Procedures:
Psychiatric Diagnosis or Evaluation, Psychiatric Therapeutic Procedures
Conditions:
Anxiety Dissociative and Somatoform Disorders, Anxiety Phobic Disorders, Attention Deficit Disorder (ADD), Bipolar Disorder, Depressive Disorders, Obsessive-Compulsive Disorder (OCD), Post Traumatic Stress Disorder (PTSD), Dementia, Schizophrenia
Languages:
English
Description:
Dr. Patel graduated from the Baroda Medical College, Gujarat, India in 1979. She works in Virginia Beach, VA and specializes in Psychiatry. Dr. Patel is affiliated with Sentara Norfolk General Hospital and Sentara Princess Anne Hospital.

Nandini D. Patel

Specialties:
Diagnostic Radiology, Neuroradiology
Work:
Fairfax Radiology CenterFairfax Radiological Consultants
6211 Centreville Rd STE 400, Centreville, VA 20121
703-6984444 (phone)
Site
Fairfax Radiology CenterFairfax Radiological Consultants
3299 Woodburn Rd STE 110, Annandale, VA 22003
703-8499050 (phone) 703-6984491 (fax)
Site
Fairfax Radiology CenterFairfax Radiological Consultants
7799 Leesburg Pike STE 104S, Falls Church, VA 22043
703-8932820 (phone) 703-8272685 (fax)
Site
Education:
Medical School
Albany Medical College
Graduated: 2004
Languages:
English, Spanish
Description:
Dr. Patel graduated from the Albany Medical College in 2004. She works in Falls Church, VA and 2 other locations and specializes in Diagnostic Radiology and Neuroradiology. Dr. Patel is affiliated with Inova Fair Oaks Hospital, Inova Fairfax Medical Campus and Inova Loudoun Hospital.

Nandini K. Patel

Specialties:
Internal Medicine
Education:
Medical School
Grant Med Coll, Univ of Mumbai, Mumbai, Maharashtra, India
Graduated: 1990
Conditions:
Acute Sinusitis, Chronic Renal Disease, Contact Dermatitis, Dermatitis, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Erectile Dysfunction (ED), Herpes Simplex, Hypertension (HTN), Migraine Headache, Osteoarthritis
Description:
Dr. Patel graduated from the Grant Med Coll, Univ of Mumbai, Mumbai, Maharashtra, India in 1990. She works in Fort Benning, GA and specializes in Internal Medicine. Dr. Patel is affiliated with Martin Army Community Hospital.
Nandini Patel Photo 1

Nandini Dhiren Patel

Specialties:
Radiology
Diagnostic Radiology
Neuroradiology
Education:
Albany Medical College (2009)

Nandini Patel resumes & CV records

Resumes

Nandini Patel Photo 31

Nutley High School

Work:
United States
Nutley High School
Nandini Patel Photo 32

Accounts Payable Intern

Work:

Accounts Payable Intern
Nandini Patel Photo 33

Nandini Patel

Nandini Patel Photo 34

Nandini Patel

Nandini Patel Photo 35

Nandini Patel

Nandini Patel Photo 36

Nandini Patel

Location:
United States

Publications & IP owners

Us Patents

Tricyclic Compounds And Their Use As Phosphodiesterase Inhibitors

US Patent:
2023000, Jan 5, 2023
Filed:
Aug 12, 2022
Appl. No.:
17/886807
Inventors:
- New York NY, US
Nandini Chaturbhai Patel - Waban MA, US
Patrick Robert Verhoest - Newton MA, US
Christopher John Helal - Mystic CT, US
Simone Sciabola - Cambridge MA, US
Erik Alphie LaChapelle - Uncasville CT, US
Travis T. Wager - Brookline MA, US
Ramalakshmi Yegna Chandrasekaran - Gales Ferry CT, US
Assignee:
PFIZER INC. - New York NY
International Classification:
C07D 471/14
C07D 491/147
C07D 491/22
C07D 513/14
C07D 519/00
C07D 487/04
C07D 487/14
C07D 498/22
C07D 471/22
Abstract:
The present invention is directed to compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein the substituents A, R, R, R, R, R, Rand n are as defined herein. The inventions also directed to pharmaceutical compositions comprising the compounds, methods of treatment using the compounds and methods of preparing the compounds.

6,7,8,9-Tetrahydro-5H-Pyrido[2,3-D]Azepine Dopamine D3 Ligands

US Patent:
2020015, May 21, 2020
Filed:
Jan 23, 2020
Appl. No.:
16/750505
Inventors:
- New York NY, US
Jaclyn Louise Henderson - Cambridge MA, US
Joseph Michael Young - Castro Valley CA, US
Travis T. Wager - Brookline MA, US
Bethany Lyn Kormos - Somerville MA, US
Nandini Chaturbhai Patel - Waban MA, US
Simone Sciabola - Cambridge MA, US
Jamison Bryce Tuttle - Marblehead MA, US
Patrick Robert Verhoest - Newton MA, US
Joseph Walter Tucker - New London CT, US
International Classification:
C07D 471/04
A61P 25/22
A61P 25/24
A61P 25/18
A61P 25/16
A61K 31/55
Abstract:
The present invention provides compounds of Formula (I): and pharmaceutically acceptable salts thereof wherein the variables R, R, R, R, R, a and A are as defined herein; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D3-mediated (or D3-associated) disorders including, e.g., substance addiction, substance abuse, schizophrenia (e.g., its cognitive symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD or PD), Parkinson's disease, mania, anxiety, impulse control disorders, sexual disorders and depression.

Imidazopyridazine Compounds

US Patent:
2019032, Oct 24, 2019
Filed:
Jun 27, 2019
Appl. No.:
16/455020
Inventors:
- New York NY, US
Nandini Chaturbhai Patel - Waban MA, US
Matthew Merrill Hayward - Old Lyme CT, US
Christopher John Helal - Mystic CT, US
Simone Sciabola - Cambridge MA, US
Erik Alphie LaChapelle - Uncasville CT, US
Joseph Michael Young - Castro Valley CA, US
Patrick Robert Verhoest - Newton MA, US
International Classification:
C07D 487/04
C07D 519/00
Abstract:
The present invention is directed to compounds of Formula I:or a pharmaceutically acceptable salt thereof, wherein the substituents R, R, R, R, and b are as defined herein. The invention is also directed to pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, and methods of preparing the compounds.

6,7-Dihydro-5H-Pyrazolo[5,1-B][1,3]Oxazine-2-Carboxamide Compounds

US Patent:
2019030, Oct 3, 2019
Filed:
May 31, 2019
Appl. No.:
16/427627
Inventors:
- New York NY, US
Nandini Chaturbhai Patel - Waban MA, US
Patrick Robert Verhoest - Newton MA, US
Christopher John Helal - Mystic CT, US
Simone Sciabola - Cambridge MA, US
Erik Alphie LaChapelle - Uncasville CT, US
Travis T. Wager - Brookline MA, US
Matthew Merrill Hayward - Old Lyme CT, US
International Classification:
C07D 498/04
C07D 519/00
Abstract:
The present invention is directed to PDE4B inhibitors of Formula I: (I) or a pharmaceutically acceptable salt thereof, wherein the substituents R, R, R, and Rare as defined herein. The invention is also directed to pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, and methods of preparing the compounds.

Tricyclic Compounds And Their Use As Phosphodiesterase Inhibitors

US Patent:
2019026, Aug 29, 2019
Filed:
Jun 9, 2016
Appl. No.:
15/736942
Inventors:
- New York NY, US
Nandini Chaturbhai Patel - Waban MA, US
Patrick Robert Verhoest - Newton MA, US
Christopher John Helal - Mystic CT, US
Simone Sciabola - Cambridge MA, US
Erik Alphie LaChapelle - Uncasville CT, US
Travis T. Wager - Brookline MA, US
Ramalakshmi Yegna Chandrasekaran - Gales Ferry CT, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
C07D 471/14
C07D 491/147
C07D 513/14
C07D 519/00
C07D 491/22
Abstract:
The present invention is directed to compounds of Formula I:or a pharmaceutically acceptable salt thereof, wherein the substituents A, R, R, R, R, R, Rand n are as defined herein. The inventions also directed to pharmaceutical compositions comprising the compounds, methods of treatment using the compounds and methods of preparing the compounds.

6,7-Dihydro-5H-Pyrazolo[5,1-B][1,3]Oxazine-2-Carboxamide Compounds

US Patent:
2019005, Feb 21, 2019
Filed:
Feb 15, 2017
Appl. No.:
16/074290
Inventors:
Nandini Chaturbhai Patel - Waban MA, US
Patrick Robert Verhoest - Newton MA, US
Christopher John Helal - Mystic CT, US
Simone Sciabola - Cambridge MA, US
Erik Alphie LaChapelle - Uncasville CT, US
Travis T. Wager - Brookline MA, US
Matthew Merrill Hayward - Old Lyme CT, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
C07D 498/04
C07D 519/00
Abstract:
The present invention is directed to compounds of Formula I:or a pharmaceutically acceptable salt thereof, wherein the substituents R, R, R, and Rare as defined herein. The invention is also directed to pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, and methods of preparing the compounds.

6,7,8,9-Tetrahydro-5H-Pyrido[2,3-D]Azepine Dopamine D3 Ligands

US Patent:
2019004, Feb 14, 2019
Filed:
Jan 9, 2017
Appl. No.:
16/069585
Inventors:
- New York NY, US
Jaclyn Louise Henderson - Cambridge MA, US
Joseph Michael Young - Castro Valley CA, US
Travis T. Wager - Brookline MA, US
Bethany Lyn Kormos - Somerville MA, US
Nandini Chaturbhai Patel - Waban MA, US
Simone Sciabola - Cambridge MA, US
Jamison Bryce Tuttle - Marblehead MA, US
Patrick Robert Verhoest - Newton MA, US
Joseph Walter Tucker - New London CT, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
C07D 471/04
Abstract:
The present invention provides compounds of Formula (I): and pharmaceutically acceptable salts thereof wherein the variables R, R, R, R, R, a and A are as defined herein; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D3-mediated (or D3-associated) disorders including, e.g., substance addiction, substance abuse, schizophrenia (e.g., its cognitive symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD or PD), Parkinson's disease, mania, anxiety, impulse control disorders, sexual disorders and depression.

Imidazopyridazine Compounds

US Patent:
2018034, Dec 6, 2018
Filed:
Aug 7, 2018
Appl. No.:
16/056968
Inventors:
- New York NY, US
Nandini Chaturbhai Patel - Waban MA, US
Matthew Merrill Hayward - Old Lyme CT, US
Christopher John Helal - Mystic CT, US
Simone Sciabola - Cambridge MA, US
Erik Alphie LaChapelle - Uncasville CT, US
Joseph Michael Young - Castro Valley CA, US
Patrick Robert Verhoest - Newton MA, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
C07D 487/04
C07D 519/00
Abstract:
The present invention is directed to compounds of Formula I:or a pharmaceutically acceptable salt thereof, wherein the substituents R, R, R, R, and b are as defined herein. The invention is also directed to pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, and methods of preparing the compounds.

Isbn (Books And Publications)

Political Parties: Development And Change In Malawi

Author:
Nandini Patel
ISBN #:
1920095268

Possible Relatives

David Patel  Dawood M Patel  Daxa R Patel  Daxaben C Patel  Daxesh T Patel  Daxeshkumar B Patel  Dayalji D Patel  Nandini P Nair  Nandini Prasad 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.